Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy
Article Abstract:
A study evaluating the effectiveness of bisphosphonates, inhibitors of osteoclasts, as earlier thought to reduce the consequences of metastatic bone disease, but reported in recent studies, as causing osteonecrosis of jaws, is presented.
Publisher: American Dental Association Publishers Inc.
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2005
Evaluation, Cover Story, Drug therapy, Bone diseases
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Bisphosphonate-related osteonecrosis of the jaws
Article Abstract:
A study on morbidity associated with bisphosphonate-related osteonecrosis of the jaw treatments is presented. The measures to be taken to diagnose and treat this disease are also presented.
Publisher: American Dental Association Publishers Inc.
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2007
Patient outcomes, Diagnosis, Dosage and administration
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Bones, Causes of, Risk factors, Osteonecrosis, Diphosphonates
Similar abstracts:
- Abstracts: Improving the care of patients with symptoms of depression. Improving support information with an integrated CNS service
- Abstracts: The eyes and ears of their patients. Cost-effectiveness and efficacy in long-term oxygen therapy. How to administer an enema
- Abstracts: Lactate dehydrogenase isoform activity mapping in patients with intra-amniotic infection. Pregnancy and estradiol modulate myometrial G-protein pathways in the guinea pig
- Abstracts: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure
- Abstracts: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. The medical management of depression
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.